@amitabhchandra2 Outcomes rebates, b/c they are not anchored to a clear cost-benefit calculation, are not 'value based'. At best, they r post hoc adjustments that may move a net price closer to a value-based price, but not necessarily. We reviewed this distinction here: https://t.co/2y0nmIWy05